Open Insider Trading Activity for Spyre Therapeutics, Inc. Chief Financial Officer Burrows Scott L
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. SYRE | 2026-06-26 | 2026-06-25 | Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sell | 2 | 15,000 | $87.13 | $1,307,000.00 | 6.79% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction SYRE | 2026-05-01 | 2026-05-01 | Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sell | 1 | 12,500 | $71.37 | $892,125.00 | 11.31% | View Filing |